Profile of Autoimmune Polyendocrinopathies at the Medical Clinic II of the Abass Ndao Hospital: About 40 Cases
- 1 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 2 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 3 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 4 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 5 Aristide Le Dantec Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 6 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 7 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 8 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 9 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 10 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 11 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 12 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 13 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 14 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
- 15 Abass Ndao Hospital, Internal Medicine Department, Cheikh Anta Diop University, Dakar, Senegal
Abstract
Introduction: Autoimmune polyendocrinopathies (AP) represent a group of rare concomitant pathologies, making them underdiagnosed. The objective was to study their profile at the Medical Clinic II of the Abass Ndao Hospital. Patients and Methods: This was an observational, descriptive and analytical study, lasting 24 months, from January 1, 2020 to December 31, 2022. We assessed the epidemiological, clinical and paraclinical characteristics of the patients and classified the APs found. Results: We included 40 patients divided into type III (38 cases) and IV (2 cases). A female predominance was noted with a sex ratio of 0.21. The mean age was 38.6 years. A family history of component diseases of autoimmune polyendocrine syndrome (APS) was found in 62.5%. Goiter (80%) was the main clinical sign present. All 38 patients with ISAP-3 had autoimmune thyroiditis, including 29 cases of Graves’ disease (72.5%) and 9 cases of Hashimoto’s thyroiditis (22.5%). They were associated with either type 1 diabetes (57.9%), Biermer’s disease (21.1%), vitiligo + alopecia (18.4%), lupus (2.6%). The 2 patients with AP-4 had Biermer’s disease associated with either Addison’s disease or type 1 diabetes. Management depended on the pathologies present and their possible complications. The immunological phenomena were also controlled. Conclusion: This series is globally similar to the literature. The polymorphous character of the clinical pictures requires a better collaboration between specialists leading to a clinical and holistic synthesis.
- Eisenbarth, G.S. and Gottlieb, P.A. (2004) Autoimmunes Polyendocrines Syndromes. The New England Journal of Medicine, 350, 2068-2079. https://doi.org/10.1056/NEJMra030158
- Neufeld, M.N. and Blizzard, R. (1980) Auto-Immune Polyglandual Syndromes. Pediatric Annals, 9, 154-162. https://doi.org/10.3928/0090-4481-19800401-07
- Kahaly, G.J. (2012) Polyglandular Autoimmune Syndrome Type II. Quaterly Medical Review, 41, 663-670. https://doi.org/10.1016/j.lpm.2012.09.011
- Ahonen, P., et al. (1985) Autoimmune Polyendocrinopathy-Candidosis-Ectodermal Dystrophy (Apeced), Autosomal Recessive Inheritance. Clinical Genetics, 27, 535-542. https://doi.org/10.1111/j.1399-0004.1985.tb02037.x
- Ahonen, P., Myllarniemi, S., Sipila, I. and Perheentupa, J. (1990) Clinical Variation of Autoimmune Polyendocrinopathy-Candidiasisectodermal Dystrophy (Apeced) in a Series of 68 Patients. The New England Journal of Medicine, 322, 1829-1836. https://doi.org/10.1056/NEJM199006283222601
- Sivarajah, S. (2006) Polyglandular Autoimmune Type II. eMedicine.
- Diagne, N., Ndao, A.C., Faye, A., et al. (2020) épidémiologie descriptive de l’association de dysthyroïdies auto-immunes avec d’autres affections auto-immunes dans un service de Médecine Interne au sud du Sahara. RAFMI, 7, 16-21.
- Betterle, C., Pradal, C. and Greggio, N. (2001) Autoimmunity in Isolated Addison’s Disease and in Polyglandular Autoimmune Diseases Type 1, 2 and 4. Annales d’Endocrinologie, 62, 193-201.
- Aung, K. (2007) Polyglandular Syndrome Type III. eMedecine.
- Rekik, N., Mnif, F., Ben Salah, S., et al. (2009) Diabète de type 1 et maladies thyroïdiennes auto-immunes au cours des polyendocrinopathies auto-immunes: à propos de 60 cas. Diabetes & Metabolism, 35, 29-89. https://doi.org/10.1016/S1262-3636(09)72052-X
- Betterle, C. and Zanchetta, R. (2003) Update on Autoimmune Polyendocrine Syndromes. Acta Biomedica Atenei Parmensis, 74, 9-33.
- Bennour, M., Rojbi, I., Rezgani, I., et al. (2017) Fréquence des pathologies auto-immunes au cours du diabète type 1. Annales d’Endocrinologie, 78, 397-433. https://doi.org/10.1016/j.ando.2017.07.684
- Fraj, A., Daadaa, S., Chaabene, I., et al. (2020) Maladies auto-immunes associées à la maladie de Biermer. Revue de Médecine Interne, 41, Article 95. https://doi.org/10.1016/j.revmed.2020.10.153